RICOF yields 2.92% · JNJ yields 2.13%● Live data
📍 RICOF pulled ahead of the other in Year 1
Combined, RICOF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of RICOF + JNJ for your $10,000?
Ricoh Company, Ltd. provides various office and commercial printing solutions and related solutions worldwide. It offers multifunctional printers, printers, industrial inkjets, garment and production printers, 3D printers, projectors, video and web conference systems, and interactive whiteboards, as well as inkjet heads and modules. The company also provides digital, spherical, single lens reflex, action, and infrared thermography cameras; and automotive stereo cameras, automotive precision machined parts, and small and low energy mobile ICs. In addition, it produces and markets thermal paper and media for food labels, clothing tags, tickets, and handy terminal papers; manufactures and sells watches; and provides magnetoencephalography systems used in brain activity measurement, indoor location information services, bed sensor systems, automated external defibrillators, integrative medical care cooperation systems, and genetic testing substances. Further, the company provides managed print, application/ business process, communication, intelligent workplace, and information technology services; and solar power facility operations and maintenance services, as well as electricity sales services. Ricoh Company, Ltd. serves manufacturing, retail, healthcare, real estate, travel and tourism, and engineering and construction sectors. The company was formerly known as Riken Optical Co., Ltd. and changed its name to Ricoh Company, Ltd. in 1963. Ricoh Company, Ltd. was founded in 1936 and is headquartered in Tokyo, Japan.
Full RICOF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.